Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4893325 | 0.86 | — | — | |
| SCHEMBL1619242 | 0.73 | — | — | |
| Potassium Ion SCHEMBL27536427 | 0.73 | — | — | |
| Zinc Ion SCHEMBL11519946 | 0.73 | — | — | |
| SCHEMBL11522331 | 0.73 | — | — | |
| Lithium Ion SCHEMBL3701330 | 0.73 | — | — | |
| Water SCHEMBL1219279 | 0.70 | — | — | |
| SCHEMBL11424841 | 0.69 | BBOX1 (0.38) | BBOX1 | |
| SCHEMBL151455 | 0.69 | — | — | |
| SCHEMBL2229655 | 0.68 | BBOX1 (0.46) | BBOX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080033209-A1 | Method For High-Purity Quaternary Ammonium Compounds | BASF AKTIENGSELLSCHAFT (DE) | 2008-02-07 | — | — | US | disclosed |
| US-20080009633-A1 | Method for Producing High-Purity Quaternary Ammonium Compounds | BASF AKTIENGESELLSCHAFT (DE) | 2008-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080033209-A1 | Method For High-Purity Quaternary Ammonium Compounds | ATL3, SMYD3, SP1 | BBOX1 3638/4885 |
| US-20080009633-A1 | Method for Producing High-Purity Quaternary Ammonium Compounds | SP1, EIF3A, EIF3H | BBOX1 4160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.